RAPP
Rapport Therapeutics, Inc.
40.50$
-3.6%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | +646.7% | +649.1% | +21.2% | |
| – | – | – | – | |
| – | +207.2% | +117.6% | +55.6% | |
| – | +498.9% | +170.4% | +37.0% | |
| – | +249.5% | +129.6% | +50.6% | |
| – | – | – | – | |
| – | -100.0% | – | – | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.